Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $2.36 on revenue of $2.49. Analysts polled by Investing.com anticipated EPS of $2.17 on revenue of $2.33B.
Quest Diagnostics shares are down 26% from the beginning of the year and are trading at $126.66 , down-from-52-week-high.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar